ZA917141B - 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments - Google Patents
3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicamentsInfo
- Publication number
- ZA917141B ZA917141B ZA917141A ZA917141A ZA917141B ZA 917141 B ZA917141 B ZA 917141B ZA 917141 A ZA917141 A ZA 917141A ZA 917141 A ZA917141 A ZA 917141A ZA 917141 B ZA917141 B ZA 917141B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrogen
- loweralkyl
- pyridinamines
- indazol
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/579,751 US5051430A (en) | 1990-09-10 | 1990-09-10 | 3-(1H-indazol-3-yl)-4-pyridinamines |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA917141B true ZA917141B (en) | 1992-04-29 |
Family
ID=24318208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA917141A ZA917141B (en) | 1990-09-10 | 1991-09-09 | 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments |
Country Status (20)
Country | Link |
---|---|
US (1) | US5051430A (ko) |
EP (1) | EP0475352B1 (ko) |
JP (1) | JP3042915B2 (ko) |
KR (1) | KR100203236B1 (ko) |
AT (1) | ATE123493T1 (ko) |
AU (1) | AU640590B2 (ko) |
CA (1) | CA2050875C (ko) |
CZ (1) | CZ280883B6 (ko) |
DE (1) | DE69110219T2 (ko) |
DK (1) | DK0475352T3 (ko) |
ES (1) | ES2074618T3 (ko) |
FI (1) | FI914219A (ko) |
HU (1) | HUT59126A (ko) |
IE (1) | IE67442B1 (ko) |
IL (1) | IL99434A (ko) |
NO (1) | NO913543L (ko) |
NZ (1) | NZ239692A (ko) |
PL (1) | PL295728A1 (ko) |
PT (1) | PT98911B (ko) |
ZA (1) | ZA917141B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT56347A (en) * | 1989-12-27 | 1991-08-28 | Hoechst Roussel Pharma | Process for producing aminopyridinylmethanol and aminomethyl pyridineamine derivatives and pharmaceutical compositions comprising such compounds |
US7211594B2 (en) | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
US6897231B2 (en) | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
JP4535680B2 (ja) * | 2001-04-16 | 2010-09-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規1h−インダゾール化合物 |
WO2005085227A1 (en) * | 2004-03-02 | 2005-09-15 | Smithkline Beecham Corporation | Inhibitors of akt activity |
US7812045B2 (en) * | 2005-03-30 | 2010-10-12 | Daewoong Pharmaceutical Co., Ltd. | Antifungal triazole derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU198036B (en) * | 1983-08-22 | 1989-07-28 | Hoechst Roussel Pharma | Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them |
-
1990
- 1990-09-10 US US07/579,751 patent/US5051430A/en not_active Expired - Fee Related
-
1991
- 1991-09-06 NZ NZ239692A patent/NZ239692A/en unknown
- 1991-09-06 CA CA002050875A patent/CA2050875C/en not_active Expired - Fee Related
- 1991-09-06 IL IL9943491A patent/IL99434A/en unknown
- 1991-09-06 FI FI914219A patent/FI914219A/fi not_active Application Discontinuation
- 1991-09-09 AU AU83716/91A patent/AU640590B2/en not_active Expired - Fee Related
- 1991-09-09 ZA ZA917141A patent/ZA917141B/xx unknown
- 1991-09-09 HU HU912901A patent/HUT59126A/hu unknown
- 1991-09-09 PT PT98911A patent/PT98911B/pt not_active IP Right Cessation
- 1991-09-09 NO NO91913543A patent/NO913543L/no unknown
- 1991-09-09 JP JP3227982A patent/JP3042915B2/ja not_active Expired - Lifetime
- 1991-09-09 CZ CS912776A patent/CZ280883B6/cs not_active IP Right Cessation
- 1991-09-09 PL PL29572891A patent/PL295728A1/xx unknown
- 1991-09-09 IE IE315791A patent/IE67442B1/en not_active IP Right Cessation
- 1991-09-10 ES ES91115280T patent/ES2074618T3/es not_active Expired - Lifetime
- 1991-09-10 EP EP91115280A patent/EP0475352B1/en not_active Expired - Lifetime
- 1991-09-10 DK DK91115280.9T patent/DK0475352T3/da active
- 1991-09-10 KR KR1019910015736A patent/KR100203236B1/ko not_active IP Right Cessation
- 1991-09-10 AT AT91115280T patent/ATE123493T1/de not_active IP Right Cessation
- 1991-09-10 DE DE69110219T patent/DE69110219T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE123493T1 (de) | 1995-06-15 |
CA2050875A1 (en) | 1992-03-11 |
CS277691A3 (en) | 1992-04-15 |
DE69110219D1 (de) | 1995-07-13 |
IL99434A (en) | 1995-08-31 |
NZ239692A (en) | 1994-01-26 |
ES2074618T3 (es) | 1995-09-16 |
CZ280883B6 (cs) | 1996-04-17 |
NO913543L (no) | 1992-03-11 |
CA2050875C (en) | 2002-07-16 |
FI914219A0 (fi) | 1991-09-06 |
KR920006346A (ko) | 1992-04-27 |
DE69110219T2 (de) | 1995-11-09 |
EP0475352B1 (en) | 1995-06-07 |
JP3042915B2 (ja) | 2000-05-22 |
JPH04247079A (ja) | 1992-09-03 |
AU640590B2 (en) | 1993-08-26 |
IE67442B1 (en) | 1996-04-03 |
PL295728A1 (en) | 1993-05-04 |
IE913157A1 (en) | 1992-03-11 |
HUT59126A (en) | 1992-04-28 |
HU912901D0 (en) | 1992-01-28 |
IL99434A0 (en) | 1992-08-18 |
PT98911A (pt) | 1992-07-31 |
KR100203236B1 (ko) | 1999-06-15 |
DK0475352T3 (da) | 1995-10-16 |
AU8371691A (en) | 1992-03-12 |
US5051430A (en) | 1991-09-24 |
NO913543D0 (no) | 1991-09-09 |
EP0475352A1 (en) | 1992-03-18 |
PT98911B (pt) | 1999-02-26 |
FI914219A (fi) | 1992-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6208990A (en) | N-substituted-4-pyrimidinamines and pyrimidindiamines, a process for their preparation and their use as medicaments | |
AU636351B2 (en) | N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments | |
EP0430201A3 (en) | Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments | |
ZA917141B (en) | 3-(1h-indazol-3-yl)-4-pyridinamines,a process and intermediates for their preparation and their use as medicaments | |
AU633791B2 (en) | 3-(1,2-benzisoxazol-3-yl)-4-pyridinamines and derivatives |